ATE370974T1 - ST RKE DERIVATIVES, ST RKE-ACTIVE SUBSTANCE CONJ UGATES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS - Google Patents

ST RKE DERIVATIVES, ST RKE-ACTIVE SUBSTANCE CONJ UGATES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS

Info

Publication number
ATE370974T1
ATE370974T1 AT03708114T AT03708114T ATE370974T1 AT E370974 T1 ATE370974 T1 AT E370974T1 AT 03708114 T AT03708114 T AT 03708114T AT 03708114 T AT03708114 T AT 03708114T AT E370974 T1 ATE370974 T1 AT E370974T1
Authority
AT
Austria
Prior art keywords
rke
derivatives
production
active substance
medicinal products
Prior art date
Application number
AT03708114T
Other languages
German (de)
Inventor
Klaus Sommermeyer
Nobert Zander
Ronald Frank
Harald Conradt
Original Assignee
Fresenius Kabi De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi De Gmbh filed Critical Fresenius Kabi De Gmbh
Application granted granted Critical
Publication of ATE370974T1 publication Critical patent/ATE370974T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

N-(Haloacetylaminoalkyl) amide derivatives (I) of carboxylic acids obtained by oxidation of optionally substituted starch are new. N-(Haloacetylaminoalkyl) amide derivatives of formula (I) of carboxylic acids obtained by oxidation of optionally substituted starch are new. X = Br or I; n = 2-10; and R-CO- = residue of oxidized, optionally substituted starch in which the reducing terminal has been oxidized to carboxylic acid. Independent claims are also included for: (1) New starch residue-containing derivatives of pharmaceutically active agents (A) containing thiol groups, having formula (II); and (2) A method for derivatizing (A), involving reaction of (A) (i.e. R'-SH) with (I). R' = residue of a thiol group containing active agent (A).
AT03708114T 2002-02-20 2003-02-20 ST RKE DERIVATIVES, ST RKE-ACTIVE SUBSTANCE CONJ UGATES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS ATE370974T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10207072A DE10207072A1 (en) 2002-02-20 2002-02-20 New N-(haloacetylaminoalkyl) amides of starch carboxylic acids, useful as modifying agents for drugs containing thiol groups, e.g. to increase solubility or plasma half-life or reduce antigenicity

Publications (1)

Publication Number Publication Date
ATE370974T1 true ATE370974T1 (en) 2007-09-15

Family

ID=27635176

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03708114T ATE370974T1 (en) 2002-02-20 2003-02-20 ST RKE DERIVATIVES, ST RKE-ACTIVE SUBSTANCE CONJ UGATES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS

Country Status (13)

Country Link
US (1) US7285661B2 (en)
EP (1) EP1476470B1 (en)
JP (1) JP2005529192A (en)
CN (1) CN1625569A (en)
AT (1) ATE370974T1 (en)
AU (1) AU2003212255B2 (en)
CA (1) CA2473068C (en)
DE (2) DE10207072A1 (en)
DK (1) DK1476470T3 (en)
ES (1) ES2289262T3 (en)
MX (1) MXPA04007068A (en)
PL (1) PL370779A1 (en)
WO (1) WO2003070772A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10112825A1 (en) * 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylation of active ingredients in aqueous solution
DE10209822A1 (en) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Coupling of low molecular weight substances to a modified polysaccharide
DE10209821A1 (en) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Coupling of proteins to a modified polysaccharide
MXPA05002594A (en) * 2002-09-11 2005-05-27 Fresenius Kabi Gmbh Hasylated polypeptides, especially hasylated erythropoietin.
ATE409048T1 (en) 2002-10-08 2008-10-15 Fresenius Kabi De Gmbh PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES
EP1473308A1 (en) * 2003-04-28 2004-11-03 B. Braun Melsungen Ag Derivatives of starch for clinic use, especially parenteral
WO2005014655A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
WO2005014024A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of a polymer and a protein linked by an oxime linking group
SG145746A1 (en) * 2003-08-08 2008-09-29 Fresenius Kabi De Gmbh Conjugates of hydroxyalkyl starch and g-csf
US20090281296A1 (en) * 2004-02-09 2009-11-12 Supramol Parenteral Colloid Gmbh Process for the production of conjugates from polysaccharides and polynucelotides
EP1732953B1 (en) * 2004-03-01 2007-11-07 B. Braun Melsungen Ag Hydroxyethyl starch
ES2390885T3 (en) * 2004-03-11 2012-11-19 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkylamidone and a protein
AR048035A1 (en) 2004-03-11 2006-03-22 Fresenius Kabi De Gmbh CONJUGADOS DE ALMIDON DE HIDROXIALQUILO AND A PROTEIN, PREPARED BY REDUCING AMINATION
AU2006222187A1 (en) * 2005-03-11 2006-09-14 Fresenius Kabi Deutschland Gmbh Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch
MX2011000859A (en) 2008-07-23 2011-02-24 Ambrx Inc Modified bovine g-csf polypeptides and their uses.
NZ600361A (en) 2009-12-21 2014-06-27 Ambrx Inc Modified bovine somatotropin polypeptides and their uses
EP2516455A4 (en) 2009-12-21 2013-05-22 Ambrx Inc MODIFIED PORCINE GROWTH HORMONE POLYPEPTIDES AND USES THEREOF
TWI480288B (en) 2010-09-23 2015-04-11 Lilly Co Eli Formulations for bovine granulocyte colony stimulating factor and variants thereof
US9382305B2 (en) 2011-07-01 2016-07-05 Bayer Intellectual Property Gmbh Relaxin fusion polypeptides and uses thereof
CN102321185B (en) * 2011-08-09 2012-12-19 武汉华科大生命科技有限公司 Synthesis method of middle-molecular-weight hydroxyethyl starch
EP3114138B1 (en) 2014-03-05 2021-11-17 Pfizer Inc. Improved muteins of clotting factor viii
AR131133A1 (en) 2023-05-24 2025-02-19 Ambrx Inc PEGYLATED BOVINE INTERFERON AND METHODS OF USE THEREOF

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2600897A1 (en) 1986-07-04 1988-01-08 Pf Medicament Proteolytic and absorbent dressing and process for its preparation
DE19628705A1 (en) * 1996-07-08 1998-01-15 Fresenius Ag New oxygen transport agents, hemoglobin-hydroxyethyl starch conjugates containing them, processes for their preparation and their use as blood substitutes
DE10135694A1 (en) * 2001-07-21 2003-02-06 Supramol Parenteral Colloids New amphiphilic conjugate of starch or hydroxyethylstarch, useful as drug carrier, contain e.g. fatty acyl residues, are not taken up by the reticuloendothelial system

Also Published As

Publication number Publication date
CA2473068A1 (en) 2003-08-28
AU2003212255B2 (en) 2009-01-22
EP1476470A1 (en) 2004-11-17
JP2005529192A (en) 2005-09-29
WO2003070772A1 (en) 2003-08-28
ES2289262T3 (en) 2008-02-01
CA2473068C (en) 2011-06-07
US20050065113A1 (en) 2005-03-24
US7285661B2 (en) 2007-10-23
PL370779A1 (en) 2005-05-30
EP1476470B1 (en) 2007-08-22
AU2003212255A1 (en) 2003-09-09
DK1476470T3 (en) 2007-11-12
CN1625569A (en) 2005-06-08
DE50308003D1 (en) 2007-10-04
MXPA04007068A (en) 2004-11-01
DE10207072A1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
DE50308003D1 (en) ST RKEDERIVATE, ST RKE-ACTIVE CONJUGATES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS
ATE314350T1 (en) MALONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS AN INHIBITOR OF FACTOR XA ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE528288T1 (en) ANTHRANILIC ACID AMIDES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS ANTIARRHYTHMICS AND PHARMACEUTICAL PREPARATIONS THEREOF
HRP20020428B1 (en) Bicyclic amino acids as pharmaceutical agents
ATE466850T1 (en) TOCOPHEROLES, TOCOTRIENOLS, OTHER CHROMENE AND SIDE CHAIN DERIVATIVES, AND THEIR USES
ATE331705T1 (en) ALPHA-AMINO ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS DIPEPTIDYLPEPTIDASE-IV INHIBITORS (DPP IV)
TR200401029T4 (en) Acylphenyl-urea derivatives, manufacturing methods and their use as pharmaceuticals
DK0624596T3 (en) Tetrazole derivatives of bile acids, method of preparation and use of these compounds as drugs
ATE175201T1 (en) MONO-N-SUBSTITUTED 1,4,7,10-TETRAAZACYCLODODECAN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING SAME
DE50011034D1 (en) N-SUBSTITUTED 4-AMINOOPTERIDINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS
ATE297723T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A 5-AMINOLAEVULIC ACID ESTER AS A PHOTOCHEMOTHERAPEUTIC AND A MUCOADHESIVE
ES2101421T3 (en) SUBSTITUTED HETERO-CYCLIC CARBOXYLIC ACID AMIDES, THEIR PREPARATION AND THEIR USE AS MEDICINES.
EP2266569A3 (en) Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
DE602005000187D1 (en) Process for the preparation of (1S) -4,5-dimethoxy-1- (methylaminomethyl) -benzocyclobutane and its acid addition salts, and their use for the synthesis of ivabradine and their acid addition salts of pharmaceutically acceptable acid
ATE547416T1 (en) PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
ATE361924T1 (en) DIHYDROPTERIDINONE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
MY134582A (en) New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments
ATE246180T1 (en) BENZOFURANONE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
EP2316830A3 (en) N-sulphonylated amino acid derivatives and their use as matriptase inhibitors
ATE402175T1 (en) 4-OXO-1-(3-SUBSTITUTEDPHENYL)-1,4-DIHYDRO-1, - NAPHTHYRIDINE-3-CARBONIC ACID AMIDE ALSPHOSHODIESTERASE-4 INHIBITORS
DE69632193D1 (en) CYCLOOXYGENAS INHIBITOR AND SALTS OF AMIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS MEDICINAL AGENTS AND MEDICINAL PRODUCTS CONTAINING THESE SALTS
DE59010254D1 (en) Quinolonecarboxylic acid derivatives, processes for their preparation and their use as antiviral agents
ATE394379T1 (en) 4-ALKOXY-CYCLOHEXANE-1-AMINO-CARBONIC ACID ESTERS AND METHOD FOR THE PRODUCTION THEREOF
DE50104557D1 (en) NEW BETA-AMYLOID INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
ATE374172T1 (en) WEXIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THERAPEUTIC USES THEREOF